---
title: Andelyn Biosciences vs Omniabio
slug_a: andelynbio
slug_b: omniabio
site: cdmo
review_signal_gate: closed
canonical_path: /compare/andelynbio/omniabio
---

# Andelyn Biosciences vs Omniabio

Side-by-side profile data from each company listing on this directory.

## Andelyn Biosciences

- Profile: [/companies/andelynbio](/companies/andelynbio)

Andelyn Biosciences — Andelyn Biosciences is a gene therapy CDMO offering AAV viral vector manufacturing, plasmid production, process development, analytical development, and quality control for clients. The company reports more than 85 INDs supported and over 500 cGMP batches produced.

Services: 14. Modalities: 3. Indications: 1. Locations: 9. Certifications: 1. The strongest documented coverage currently appears in services (14).

### Services

- Cell-Line Development
- Upstream Processing
- Downstream Processing
- Viral Vector Manufacturing
- AAV Manufacturing
- Lentiviral Vector Manufacturing
- Cell Therapy Manufacturing
- Sterile Fill-Finish & Aseptic Manufacturing
- Process Development
- Technology Transfer
- CMC Analytical Development
- Quality Control Testing
- Stability Testing & Storage
- CMC Regulatory Submission Support

### Modalities

- Cell Therapy
- Gene Therapy
- AAV / Viral Vector Platform

### Development capabilities

- Analytical method development
- Cell line development

### Manufacturing capabilities

- Drug Substance (DS)
- Drug Product (DP)
- Max bioreactor: Mid-scale clinical (≤2,000 L)
- Expression: Mammalian
- Expression: Microbial
- Expression: Viral Vector
- Single-Use / Disposable

## Omniabio

- Profile: [/companies/omniabio](/companies/omniabio)

Omniabio — OmniaBio is a cell and gene therapy CDMO specializing in process development, analytical development, and GMP manufacturing for lentiviral vectors, iPSCs, and immune cell-based therapies. The company operates a 120,000 sq ft facility in Hamilton, Ontario, integrating AI, automation, and robotics to deliver scalable manufacturing from preclinical to commercial stages.

Services: 8. Modalities: 2. Indications: 0. Locations: 1. Certifications: 0. The strongest documented coverage currently appears in services (8).

### Services

- Cell-Line Development
- Lentiviral Vector Manufacturing
- Cell Therapy Manufacturing
- Autologous Cell Therapy Manufacturing
- Allogeneic Cell Therapy Manufacturing
- Process Development
- CMC Analytical Development
- CMC Regulatory Submission Support

### Modalities

- Cell Therapy
- Gene Therapy

### Development capabilities

- Analytical method development
- Cell line development

### Manufacturing capabilities

- Drug Substance (DS)
- Drug Product (DP)